SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,958.00    80.00 (2.78%)
Bid:
2,950.00
Ask:
2,956.00
Spread: 6.00 (0.203%)
Market Cap: £1.63b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Half Year Trading Update

16 Oct 2024 07:00

RNS Number : 3121I
Oxford Instruments PLC
16 October 2024
 

 

Oxford Instruments plc

Half-year trading update - 16 October 2024

 

 

Robust demand and order intake growthFull year trading in line with constant currency expectations

 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2024.

 

At constant currency, we expect to deliver circa 10% revenue growth for the first half, supported by order intake circa 3% ahead of the prior year. Adjusted operating profit will be slightly above last year. Group margin will be lower than last year, as expected, reflecting the mix effect of stronger revenue growth from Advanced Technologies.

 

On a reported basis, the currency headwind will result in adjusted operating profit and margin below the comparable period last year.

 

Imaging & Analysis

We have continued to see good growth in the first half of this financial year, with strong demand across our materials analysis and semiconductor markets. This more than offset softer demand from our healthcare & life science market. The division recorded a positive book-to-bill in the half year.

 

Advanced Technologies

Our compound semiconductor business continues to perform well, with strong revenue growth in the first half. In the quantum market, we have begun deliveries of an ongoing series of orders to a key customer, supporting good progress towards a return to profitability. The division continues to have good order book visibility.

 

Outlook

We expect to deliver our normal stronger second half trading performance. This will be supported by the execution of some larger orders in Advanced Technologies, as well as progress in our operational transformation and business restructuring projects, delivering efficiency and cost improvements in the second half of the year. We expect performance for the full year to be in line with expectations on a constant currency basis.

 

Based on prevailing exchange rates, the appreciation of sterling is expected to increase the currency headwind on operating profit for the full year by circa £1.5-2.0m from previous guidance.2

 

Oxford Instruments' results for the half year ending 30 September 2024 will be released on 12 November 2024.

 

 

Notes:

 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and the mark-to-market revaluation of financial derivatives.

2. Guidance in our 2024 preliminary full-year results announcement in June pointed to a headwind of £8.4m to revenue and £6.2m to profit for the full year.

 

 

Enquiries:

 

Oxford Instruments plc

Richard Tyson, Chief Executive Officer

Gavin Hill, Chief Financial Officer

Stephen Lamacraft, Head of Investor Relations

 

Tel: 01865 393200

investors@oxinst.com

 

MHP Group

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

 

Tel: 07710 117517

oxfordinstruments@mhpgroup.com

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow.

Oxford Instruments holds a unique position to anticipate global drivers and connect academic researchers with commercial applications engineers, acting as a catalyst that powers real world progress.

Founded in 1959 as the first technology business to be spun out fromOxfordUniversity, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG).

For more information, visit www.oxinst.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKPBQABDDPKD
Date   Source Headline
16th Jun 20217:00 amRNSOxford Instruments agrees to buy WITec GmbH
11th Jun 202110:58 amPRNDirector/PDMR Shareholding
8th Jun 20217:00 amRNSPreliminary Results
3rd Jun 202112:49 pmPRNTotal Voting Rights
11th May 20212:13 pmPRNDirector/PDMR Shareholding
22nd Apr 20219:50 amPRNDirector/PDMR Shareholding
6th Apr 20213:43 pmPRNHolding(s) in Company
26th Mar 20217:00 amRNSTrading Update
11th Mar 20215:05 pmPRNDirector/PDMR Shareholding
10th Mar 20219:12 amPRNHolding(s) in Company
4th Mar 20214:48 pmPRNHolding(s) in Company
11th Feb 20214:24 pmPRNHolding(s) in Company
11th Feb 20211:26 pmPRNDirector/PDMR Shareholding
4th Feb 20214:42 pmPRNHolding(s) in Company
27th Jan 20218:00 amPRNDirectorate Change
12th Jan 202110:56 amPRNDirector/PDMR Shareholding
7th Jan 20214:09 pmPRNTotal Voting Rights
7th Jan 20213:29 pmPRNBlocklisting - Interim Review
11th Dec 202011:27 amPRNDirector/PDMR Shareholding
3rd Dec 20201:22 pmPRNTotal Voting Rights
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
17th Nov 202010:51 amPRNDirector/PDMR Shareholding-2nd amendment
17th Nov 202010:35 amPRNDirector/PDMR Shareholding - amendment
17th Nov 20208:58 amPRNDirector/PDMR Shareholding
12th Nov 20203:04 pmPRNDirector/PDMR Shareholding
10th Nov 20207:00 amRNSHalf-year results
15th Oct 202010:20 amPRNHolding(s) in Company
14th Oct 20201:29 pmPRNDirector/PDMR Shareholding
8th Oct 20204:04 pmPRNTotal Voting Rights
24th Sep 202010:33 amPRNDirector/PDMR Shareholding
14th Sep 202012:52 pmPRNHolding(s) in Company
10th Sep 20204:31 pmPRNDirector/PDMR Shareholding
8th Sep 20202:58 pmPRNTotal Voting Rights
8th Sep 20202:48 pmPRNResult of AGM
8th Sep 20207:00 amRNSChairman’s AGM Statement 2020
7th Sep 202012:27 pmPRNHolding(s) in Company
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
25th Aug 202012:02 pmRNSPrice Monitoring Extension
20th Aug 202012:02 pmRNSPrice Monitoring Extension
19th Aug 202012:02 pmRNSPrice Monitoring Extension
18th Aug 202012:03 pmRNSPrice Monitoring Extension
11th Aug 202010:05 amPRNAdditional Listing
11th Aug 20209:51 amPRNDirector/PDMR Shareholding
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
6th Aug 202012:07 pmRNSSecond Price Monitoring Extn
6th Aug 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.